Corbion, which specializes in lactic acid and derivatives, recently announced the acquisition of substantially all assets of TerraVia Holdings (formerly Solazyme), which will result in an expansion of its product platform to include microalgae-based food and specialty ingredients.

Corbion has paid a cash purchase price of around $20m but it expects the total investments to be more than the purchase price given that TerraVia’s operations are reportedly losing money.  However, the acquisition is expected to bring high value creation potential such as omega-3 oils for animal nutrition, tailored oils, structured fats and proteins for food, personal care and industrial applications.

TerraVia has an R&D center and pilot facility in San Francisco, a demonstration plant in Peoria, Illinois, and an industrial-scale plant in Brazil in a joint venture (50.1% owned by TerraVia) with Bunge. As co-owner of the SB Oils joint venture in Brazil, Corbion will also guarantee half of the JV’s $45m outstanding debt.

I have written a more comprehensive article on TerraVia’s assets, previous collaborations/partnerships and overview of some of the bio-based chemical industry’s M&As and restructuring in the August issue of Tecnon OrbiChem’s Biomaterials newsletter.

It will be interesting to hear what Corbion plans to do next with TerraVia’s IP portfolio and R&D pipeline.